Related Experiment Video

Updated: Sep 2, 2025

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells
08:35

In Situ Immunofluorescent Staining of Autophagy in Muscle Stem Cells

Published on: June 12, 2017

10.3K

Promoting autophagy to mitigate coronavirus disease pathology in the elderly

Abby Lund Da Costa1, Het Mehta1, Ramkumar Mathur1

  • 1Department of Geriatrics, School of Medicine and Health Science University of North Dakota Grand Forks USA.

Clinical and Translational Discovery
|August 9, 2022
PubMed

Insights

Autophagy decline in elderly increases COVID-19 severity. A new study shows SF2523 enhances autophagy, reducing SARS-CoV-2 replication and mortality, offering a promising therapeutic strategy.

Area of Science:

  • Cellular biology
  • Immunology
  • Virology
  • Gerontology

Background:

  • Autophagy, a cellular degradation process, declines with age, contributing to immune system dysregulation and increased susceptibility to infections.
  • The elderly population exhibits reduced vaccine efficacy and faces a higher risk of severe outcomes from SARS-CoV-2 infection.
  • There is an urgent need for effective therapeutic interventions against coronavirus disease 2019 (COVID-19) in older adults.

Purpose of the Study:

  • To highlight the critical role of autophagy in the context of aging and SARS-CoV-2 infection.
  • To identify potential therapeutic targets for COVID-19 in the elderly population.
  • To evaluate the efficacy of SF2523 as an autophagy-inducing agent against SARS-CoV-2.

Main Methods:

  • Review and commentary on existing research, specifically citing the study by Acharya et al. (2022).
  • Analysis of SF2523's effect on autophagy induction.
  • Assessment of SF2523's impact on SARS-CoV-2 replication in vitro.
  • Evaluation of synergistic effects between SF2523 and existing antiviral medications (remdesivir, MU-UNMC).

Main Results:

  • SF2523 was demonstrated to induce autophagy, a process crucial for clearing viral infections.
  • Treatment with SF2523 significantly reduced SARS-CoV-2 replication.
  • SF2523 exhibited a synergistic effect when combined with remdesivir or MU-UNMC across various dosages.

Conclusions:

  • SF2523 represents a promising therapeutic candidate for managing SARS-CoV-2 infections, particularly in the elderly.
  • The autophagy-enhancing properties of SF2523 may offer a novel strategy to combat COVID-19.
  • Combination therapy with SF2523 and other antivirals could enhance treatment efficacy and reduce SARS-CoV-2-related mortality.

More Related Videos

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells09:10

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells

Published on: October 28, 2019

7.3K
Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

31.5K

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.7K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
4.0K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K